vor 2 Jahren

Issue 01/2017

  • Text
  • Bioplastics
  • Biobased
  • Materials
  • Biodegradable
  • Packaging
  • Plastics
  • Products
  • Foam
  • Renewable
  • Sustainable

Content Imprint Events 8

Content Imprint Events 8 bio!PAC Automotive 10 Biobased engineering plastic for Mazda’s Roadstar RF 11 Panels for trucks and buses 12 Responsible Sourcing of Biomaterials for Epichlorohydrin 14 Biobased materials – The future for the automotive industry 16 New ABS reinforced with natural fibers 18 New automotive applications for bio-PA Report 22 25 years of biodegradable testing 39 Bioplastics Survey From Science and Research 28 How prawn shopping bags could save the planet 30 Chitosan-based polymer developed to patch wounds Book Review 29 Book Review Foam 32 Starch based particle foam for biodegradable packaging 33 The biodegradable foam market in China 34 PLA based particle foam 36 New compostable particle foam Brand Owners 38 Brand Owners Perspective 01|2017 Jan / Feb Basics 40 Can additives make plastics biodegradable? Ten Years Ago 41 “Advancing Bioplastics from Down Under” (Foam 2007) 3 Editorial 5 News 20 Material News 26 Application News 42 Glossary 46 Suppliers Guide 49 Event Calendar 50 Companies in this issue Publisher / Editorial Dr. Michael Thielen (MT) Karen Laird (KL) Samuel Brangenberg (SB) Head Office Polymedia Publisher GmbH Dammer Str. 112 41066 Mönchengladbach, Germany phone: +49 (0)2161 6884469 fax: +49 (0)2161 6884468 Media Adviser Samsales (German language) phone: +49(0)2161-6884467 fax: +49(0)2161 6884468 Chris Shaw (English language) Chris Shaw Media Ltd Media Sales Representative phone: +44 (0) 1270 522130 mobile: +44 (0) 7983 967471 and Michael Thielen (see head office) Layout/Production Kerstin Neumeister Print Poligrāfijas grupa Mūkusala Ltd. 1004 Riga, Latvia bioplastics MAGAZINE is printed on chlorine-free FSC certified paper. Print run: 3,400 copies bioplastics magazine ISSN 1862-5258 bM is published 6 times a year. This publication is sent to qualified subscribers (149 Euro for 6 issues). bioplastics MAGAZINE is read in 92 countries. Every effort is made to verify all Information published, but Polymedia Publisher cannot accept responsibility for any errors or omissions or for any losses that may arise as a result. No items may be reproduced, copied or stored in any form, including electronic format, without the prior consent of the publisher. Opinions expressed in articies do not necessarily reflect those of Polymedia Publisher. All articles appearing in bioplastics MAGAZINE, or on the website are strictly covered by copyright. bioplastics MAGAZINE welcomes contributions for publication. Submissions are accepted on the basis of full assignment of copyright to Polymedia Publisher GmbH unless otherwise agreed in advance and in writing. We reserve the right to edit items for reasons of space, clarity or legality. Please contact the editorial office via The fact that product names may not be identified in our editorial as trade marks is not an indication that such names are not registered trade marks. bioplastics MAGAZINE tries to use British spelling. However, in articles based on information from the USA, American spelling may also be used. Envelopes A part of this print run is mailed to the readers wrapped in BoPLA envelopes sponsored by Taghleef Industries, S.p.A. Maropack GmbH & Co. KG, and SFV Verpackungen Cover Fotolia: Fisher Photostudio Follow us on twitter: Like us on Facebook:

daily upated news at News MHG’s updated corporate identity back into “Danimer“ Meredian Holdings Group Inc., “MHG”, a leading biopolymer manufacturer, announced in late December that it will do business as Danimer Scientific, effective immediately. MHG’s updated corporate identity is a visual salute to their solid, steadfast origins as a biotechnology company committed to sustainability and the development of innovative bioplastic products that do not contribute to global pollution. Danimer Scientific was originally formed in 2004 and provided sustainable polymer solutions by developing compostable and biodegradable plastic alternatives. Following many years of successful R & D, relationship building, and B-to-B launches of bioplastic products for use in consumer and business applications, the Company has decided to reenergize and emphasize the original corporate identity. ”The adoption of our founding name and logo marks a significant milestone as we dedicate ourselves to future product innovation and the development of global-scale solutions to plastic pollution,” stated CEO Stephen Croskrey. “The renewal of our corporate identity signals an exciting time for the company as we intensify our dedication to the development of dynamic biopolymer solutions, like our completely biodegradable PHA plastic for widespread commercial use.” In 2007, the founders of Danimer Scientific acquired the intellectual property from Procter & Gamble, “P&G”, for NodaxTM PHA. Nodax PHA was created by the distinguished Dr. Isao Noda while at P&G and he is now a Member of the Board of Directors at Danimer Scientific. Nodax PHA possesses a full spectrum of physical properties that have been proven capable of replacing many short-term use petroleum-based plastics, for both performance and price. Danimer Scientific’s Nodax PHA received OK Marine Biodegradable certification from Vinçotte International, the first such validation awarded to a biopolymer. The exciting biopolymer also has a total of six Vinçotte certifications and statements of aerobic and anaerobic compostability and biodegradability in soil, fresh water, salt water, and industrial and home compost. Danimer Scientific currently operates two facilities with well over 200,000 square feet of state-of-the-art laboratory and manufacturing/testing space. Recently, the Company announced the appointment of their new Chief Executive Officer, Stephen Croskrey, who is pioneering the Company’s planned eightfold expansion of the current PHA biorefinery. MT JV to produce biosuccinic acid in China With an eye to gaining a strong foothold in the world’s largest succinic acid market, Canada’s BioAmber Inc. and South Korean-based CJ CheilJedang Corporation (CJCJ) have announced that they have signed a nonbinding letter of intent, under which the two companies will establish a Chinese joint venture. The goal: to competitively produce bio-succinic acid in China and rapidly penetrate the Asian market. The new facility would produce up to 36,000 tonnes of biosuccinic acid annually and commercialize the output in Asia to accelerate sales growth. In the announcement, the companies state that this can be achieved rapidly, cost effectively and with limited capital investment by retrofitting an existing CJCJ fermentation facility with BioAmber’s succinic acid technology. CJCJ would incur all capital costs required to retrofit their fermentation facility, including the capital needed during plant commissioning and startup, and production would begin in Q1 2018. If market demand were to subsequently exceed production capacity, the joint venture could expand production through debottlenecking and/or additional investment. The partners would also have a mutual right-of-first-refusal to retrofit additional CJCJ fermentation facilities globally. The joint venture could offer BioAmber a quick route to the Chinese and broader Asian market, as well as serve as a blueprint for the build-out of additional bio-succinic acid production with very limited capital investment, noted Jean-Francois Huc, BioAmber’s CEO. For CJCJ, it would provide an opportunity to utilize their existing fermentation assets more effectively: “In order to competitively supply the growing market for bio-succinic acid in Asia,” explained Dr. Hang Duk Roh, Head of CJ CheilJedang BIO. CJCJ would own 65% of the JV and BioAmber would own 35%. The JV would pay BioAmber a technology royalty for having access to BioAmber’s proven biosuccinic acid technology, and would pay CJCJ a tolling fee for producing bio-succinic acid on behalf of the JV. Both partners would be entitled to a share of the profits equal to their respective equity ownership positions. Huc emphasized that the company would remain focused on ramping up operations at the Sarnia site and building a second plant in North America. However: “This JV is an opportunity for BioAmber to accelerate the deployment of its bio-succinic acid technology on a global scale without capital investment,” he said. Fabrice Orecchioni, BioAmber’s COO, added: “CJCJ has visited our Sarnia facility and we have visited their intended plant in China. Both partners are confident that the China plant can be reconfigured to quickly produce bio-succinic acid, for a fraction of what it cost us to build our Sarnia facility.” KL bioplastics MAGAZINE [01/17] Vol. 12 5

bioplastics MAGAZINE ePaper